New stem cell research unlocks unknown therapies

May 21, 2009

New treatments for the devastating Parkinson's disease and ALS are in clinical studies in Sweden, thanks to breaking new stem cell research. This news was presented today by Dr. Jonas Frisen, Professor of stem cell research at Karolinska Institutet, at the world's largest biotech convention, BIO 2009 in Atlanta.

" and regenerative medicine are in an extremely exciting phase right now. We are gaining knowledge very fast and many companies are being formed and are starting in different areas," says Dr Jonas Frisén.

As an example, a first-in-human study was just initiated for patients with the drug product, sNN0031, from the Swedish company NeuroNova. The drug, which is administered into the fluid-filled cavities of the brain, has shown long lasting recovery and formation of new cells in animal models of Parkinson's disease. Last year, a treatment for ALS entered the clinical trial phase.

Disorders in the brain and nervous system result in more hospitalizations than any other disease group, and treatments entail large costs to society. The research field of neuroscience is one of Sweden's finest. This had resulted in achievements within numerous areas of basic science with considerable scope to direct clinical applications. These include research advances concerning the origin and repair of nerve cell damage following stroke and spinal cord injury, as well as research into major degenerative diseases such as Parkinson's and Alzheimer's.

Source: Karolinska Institutet (news : web)

Explore further: Molecule enhances copper's lethal punch against microbes

add to favorites email to friend print save as pdf

Related Stories

The brain's reserve cells can be activated after stroke

Feb 23, 2009

(PhysOrg.com) -- Scientists at the Swedish medical university Karolinska Institutet have found a way of activating the neuronal reserves in the brains of mice by switching off the signal that inhibits the formation of new ...

Creatine Parkinson trial begins

Mar 26, 2007

A large-scale national clinical trial has started to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease.

Calif. institute budgets stem cell funds

Oct 05, 2006

The California Institute for Regenerative Medicine has decided how to spend the $3 billion approved by the U.S. state's voters for stem cell research.

Recommended for you

Breakthrough in understanding of important blood protein

5 hours ago

The human body contains a unique protein that has the unusual property of destroying itself after a few hours of existence - it must therefore be continually recreated and is no stable protein. The protein, ...

User comments : 0